Literature DB >> 28969958

Status for clinically complete remission rectal cancer after concomitant chemo-radiotherapy in Taiwan.

Geng-Ping Lin1, Kuan-Der Lee2, Jeng-Yi Wang3, Jinn-Shiun Chen3, Chun-Ju Chiang4, Chien-Yuh Yeh5.   

Abstract

Treatment for Rectal cancer changed after the induction of concomitant chemo-radiotherapy, CCRT. Complete remission of the tumor leads to debate of the necessity of surgical intervention. We evaluate the treatment outcome to know if operation is beneficial to these patients. Patients received long course concomitant chemo-radiotherapy for advanced rectal cancer between 2004 and 2013 in Taiwan were enrolled. Total 2780 patients diagnosed advanced rectal cancer were enrolled. In these patients, 2578 received surgical intervention and 202 were in wait and see for complete remission tumor. Higher local recurrence rate was found with wait and see group (8.9% vs. 2.7%). Also, better overall survival, disease free survival and local recurrence free survival were seen with the surgical intervention group. Surgical intervention may be benefit for some misdiagnosed completed response to CCRT.
Copyright © 2017. Published by Elsevier Taiwan.

Entities:  

Keywords:  Complete remission; Long course CCRT; Rectal cancer; Watch and wait

Mesh:

Year:  2017        PMID: 28969958     DOI: 10.1016/j.asjsur.2017.07.002

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  2 in total

1.  MRI Assessment of Complete Response to Preoperative Chemoradiation Therapy for Rectal Cancer: 2020 Guide for Practice from the Korean Society of Abdominal Radiology.

Authors:  Seong Ho Park; Seung Hyun Cho; Sang Hyun Choi; Jong Keon Jang; Min Ju Kim; Seung Ho Kim; Joon Seok Lim; Sung Kyoung Moon; Ji Hoon Park; Nieun Seo
Journal:  Korean J Radiol       Date:  2020-07       Impact factor: 3.500

2.  Efficacy and safety of wait and see strategy versus radical surgery and local excision for rectal cancer with cCR response after neoadjuvant chemoradiotherapy: a meta-analysis.

Authors:  Guo-Hua Zhao; Li Deng; Dong-Man Ye; Wen-Hui Wang; Yan Yan; Tao Yu
Journal:  World J Surg Oncol       Date:  2020-08-31       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.